You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Clinical Vector for TCR Immunotherapy Targeted to Melanoma
SBC: LENTIGEN CORPORATION Topic: NCIDESCRIPTION (provided by applicant): This Phase II proposal is a continuation of our Phase I award, Lentiviral Vectors for TCR Immunotherapy Targeted to Melanoma. We have successfully achieved the milestones laid out in our initial application. We generated a lentiviral gene vector capable of expressing a T cell receptor (TCR) specific for the tyrosinase:368-376 epitope, and demonstrated the act ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Waveform Agile, Low-cost Multi-function Radio Frequency ISR in Contested Environment
SBC: Technology Service Corporation Topic: AF151145Technology Service Corporation (TSC) will develop innovative waveforms and exploitation algorithms for concurrent synthetic aperture radar (SAR) and moving target indication (MTI) in contested RF environments to counter emerging threats from commercial un
SBIR Phase II 2017 Department of DefenseAir Force -
AUTO-SCAN: Inlet and Exhaust Damage Registration Sensor
SBC: Intelligent Automation, Inc. Topic: AF121C125ABSTRACT: Current methods for inspecting aircraft engine inlet and exhaust cavities are labor intensive and error prone. Airmen crawl into ducts looking for defects, trace suspected sites on Mylar sheets noting their position relative to cavity features, and manually enter the data into an aircraft assessment system. Technology that can reduce inspection times and eliminate sources of human err ...
SBIR Phase II 2014 Department of DefenseAir Force -
VGo-Assist, A Mobile Telepresence Robot to Engage Persons with Alzheimer's Disease and Related Dementias
SBC: VECNA TECHNOLOGIES, INC Topic: NIAProject Summary/Abstract Assistive Technologies (AT) is a broad area of activities to support physical health, well-being, social connectedness, and ability to live independently at home. Assistive Robotics (AR) has largely referred to robots that assisted people through physical interaction, while Socially Interactive Robotics (SIR) describe machines that interact primarily through social interac ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
ARPA-H-01 TOPIC: STREPAPP: DEEP LEARNING TO DIAGNOSE STREPTOCOCCAL PHARYNGITIS
SBC: AUSCULTECH DX LLC Topic: AH01This Phase II project is for the advancement of diagnostic capabilities for detecting Group A Streptococcus pharyngitis (GAS). The goals under the contract include a comprehensive and diverse database, multiple trained and optimized deep learning models deployable on a mobile device, FDA clearance for the algorithms, and the validation of the app's performance through clinical research. These achi ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Tactical Efficient Response and Replay Application (TERRA) STRATFI Proposal
SBC: Armaments Research Company, Inc. Topic: AF193DCSO1The 371st Special Operations Combat Training Squadron (371 SOCTS), Air Force Special Operations Command (AFSOC), and the United States Air Force (USAF) lack the required tools to enable commanders’ rapid, reliable, and precise information sharing to enabl
SBIR Phase II 2023 Department of DefenseAir Force -
Development of VLP vaccine for RSV
SBC: SIGMOVIR BIOSYSTEMS, INC. Topic: NIAIDRespiratory syncytial virus (RSV) is a significant human pathogen severely impacting neonates and young children, but no vaccine exists to protect this vulnerable population. Furthermore, direct vaccination of neonates is likely ineffective due to the immaturity of their immune system, and neonate immunization is potentially unsafe. The current view is that maternal vaccination is the best and saf ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
MOTAR STRATFI
SBC: DYNEPIC, INC. Topic: J201CSO1Dynepic’s STRATFI solution continues the efforts of the completed Phase II SBIR to continue, extend, scale and enhance the features and capabilities of MOTAR. STRATFI funding provides the remaining core capabilities to make MOTAR a viable and sustainable XR ecosystem. MOTAR provides a secure digital infrastructure to save time and money to deliver a platform with the critical capabilities requir ...
SBIR Phase II 2023 Department of DefenseAir Force -
Commercialization Readiness Pilot (CRP) to maximize vamorolone international labeling and sales
SBC: REVERAGEN BIOPHARMA, INC. Topic: NINDSAbstract Vamorolone is a first-in-class dissociative steroidal drug that is being developed for Duchenne muscular dystrophy as a replacement for corticosteroid standard of care (prednisone, deflazacort) by small business ReveraGen BioPharma. ReveraGen completed first-in-patient studies with the aid of a NINDS SBIR Direct-to- Phase II award (48 DMD boys; sequential clinical trials VBP15-002, VBP15- ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine
SBC: PROFECTUS BIOSCIENCES, INC. Topic: NIAIDDESCRIPTION: The HIV pandemic is one of the greatest public health challenges in history. It is estimated that 33 million people are living with HIV and 2.7 million of those are newly infected In a number of developed countries, the risk of death associated with HIV-1 infection has sharply declined due to the use of highly active antiretroviral therapy (HAART). Unfortunately, the rate of new HIV i ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health